Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 03, 2007. The report details a specific corporate action regarding the repurchase of the company's own ordinary shares in accordance with shareholder authority granted at the Annual General Meeting on May 17, 2006.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the share repurchase price of 1,397.4584 pence per share.
Material Changes
On April 03, 2007, the Company purchased 560,000 of its Ordinary shares of 25 pence each. These shares are intended to be held in Treasury. Following this transaction, the total number of shares held in Treasury increased to 282,542,678.
Outlook and Management Commentary
The filing contains no guidance, outlook, or management commentary regarding future operations or risks. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities and conforms to the Transparency Directive's transitional provision 6.
Investor Verification Points
- Verify the total number of shares in issue excluding Treasury shares, reported as 5,727,982,568.
- Confirm the updated Treasury share count of 282,542,678 for calculating voting rights and disclosure thresholds.
- Note that this filing is a notification of a share buyback and does not contain financial performance results.